Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10361)
All Articles published online
|
Publishing Process of This Article
|
Mar 14, 2017 (publication date) through Apr 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Sun C, Wang FJ, Zhang HG, Xu XZ, Jia RC, Yao L, Qiao PF. miR-34a mediates oxaliplatin resistance of colorectal cancer cells by inhibiting macroautophagy via transforming growth factor-β/Smad4 pathway. World J Gastroenterol 2017; 23(10): 1816-1827 [PMID: 28348487 DOI: 10.3748/wjg.v23.i10.1816] |
|---|---|
| URL: | https://www.wjgnet.com/2150-5349/full/v23/i10/1816.htm |
| Number | Citing Articles |
| 1 |
Jiehong Kong, Weipeng Wang. <p>A Systemic Review on the Regulatory Roles of miR-34a in Gastrointestinal Cancer</p>. OncoTargets and Therapy 2020; : 2855 doi: 10.2147/OTT.S234549
|
| 2 |
Ru Huang, Wenchao Gu, Bin Sun, Lei Gao. Identification of COL4A1 as a potential gene conferring trastuzumab resistance in gastric cancer based on bioinformatics analysis. Molecular Medicine Reports 2018; doi: 10.3892/mmr.2018.8664
|
| 3 |
Veronika Vymetalkova, Pavel Vodicka, Sona Vodenkova, Sergio Alonso, Regine Schneider-Stock. DNA methylation and chromatin modifiers in colorectal cancer. Molecular Aspects of Medicine 2019; 69: 73 doi: 10.1016/j.mam.2019.04.002
|
| 4 |
Mariangela De Robertis, Maria Luana Poeta, Emanuela Signori, Vito Michele Fazio. Current understanding and clinical utility of miRNAs regulation of colon cancer stem cells. Seminars in Cancer Biology 2018; 53: 232 doi: 10.1016/j.semcancer.2018.08.008
|
| 5 |
Hekmat M. El Magdoub, Mona F. Schaalan, Rania M. Rahmo, Doaa B. Farag, Lobna H. Khedr. Implications of miRNAs on TGF-β/TAK1/mTOR pathway in mediating the renoprotective effects of pentoxifylline against cisplatin-induced nephrotoxicity in rats. Toxicology and Applied Pharmacology 2020; 404: 115184 doi: 10.1016/j.taap.2020.115184
|
| 6 |
Jana Maslankova, Ivana Vecurkovska, Miroslava Rabajdova, Jana Katuchova, Milos Kicka, Michala Gayova, Vladimir Katuch. Regulation of transforming growth factor-β signaling as a therapeutic approach to treating colorectal cancer. World Journal of Gastroenterology 2022; 28(33): 4744-4761 doi: 10.3748/wjg.v28.i33.4744
|
| 7 |
Mohammad Hossein Pourhanifeh, Massoud Vosough, Maryam Mahjoubin-Tehran, Maryam Hashemipour, Majid Nejati, Mohammad Abbasi-Kolli, Amirhossein Sahebkar, Hamed Mirzaei. Autophagy-related microRNAs: Possible regulatory roles and therapeutic potential in and gastrointestinal cancers. Pharmacological Research 2020; 161: 105133 doi: 10.1016/j.phrs.2020.105133
|
| 8 |
Asha Kumari, Zainab Shonibare, Mehri Monavarian, Rebecca C. Arend, Nam Y. Lee, Gareth J. Inman, Karthikeyan Mythreye. TGFβ signaling networks in ovarian cancer progression and plasticity. Clinical & Experimental Metastasis 2021; 38(2): 139 doi: 10.1007/s10585-021-10077-z
|
| 9 |
Stamatia-Maria Rapti, Christos K. Kontos, Spyridon Christodoulou, Iordanis N. Papadopoulos, Andreas Scorilas. miR-34a overexpression predicts poor prognostic outcome in colorectal adenocarcinoma, independently of clinicopathological factors with established prognostic value. Clinical Biochemistry 2017; 50(16-17): 918 doi: 10.1016/j.clinbiochem.2017.06.004
|
| 10 |
Maoduo Zhang, Ying Yi Zhang, Yongze Chen, Jia Wang, Qiang Wang, Hezhe Lu. TGF-β Signaling and Resistance to Cancer Therapy. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.786728
|
| 11 |
Marco Rossi, Muhammad Jahanzaib Anwar, Ahmad Usman, Ali Keshavarzian, Faraz Bishehsari. Colorectal Cancer and Alcohol Consumption—Populations to Molecules. Cancers 2018; 10(2): 38 doi: 10.3390/cancers10020038
|
| 12 |
Nicole R. DeSouza, Danielle Quaranto, Michelle Carnazza, Tara Jarboe, Raj K. Tiwari, Jan Geliebter. Interactome of Long Non-Coding RNAs: Transcriptomic Expression Patterns and Shaping Cancer Cell Phenotypes. International Journal of Molecular Sciences 2023; 24(12): 9914 doi: 10.3390/ijms24129914
|
| 13 |
Atena Soleimani, Majid Khazaei, Gordon A Ferns, Mikhail Ryzhikov, Amir Avan, Seyed Mahdi Hassanian. Role of TGF‐β signaling regulatory microRNAs in the pathogenesis of colorectal cancer. Journal of Cellular Physiology 2019; 234(9): 14574 doi: 10.1002/jcp.28169
|
| 14 |
Ion Cristóbal, Blanca Torrejón, Andrea Santos, Melani Luque, Marta Sanz-Alvarez, Federico Rojo, Jesús García-Foncillas. Dissecting the therapeutic implications of the complex SMAD4 regulatory network in metastatic colorectal cancer. European Journal of Surgical Oncology 2018; 44(8): 1283 doi: 10.1016/j.ejso.2018.04.021
|
| 15 |
Bernadette Neve, Nicolas Jonckheere, Audrey Vincent, Isabelle Van Seuningen. The Chemical Biology of Long Noncoding RNAs. RNA Technologies 2020; 11: 229 doi: 10.1007/978-3-030-44743-4_9
|
| 16 |
Qing Cao, Ye Tian, Zhiyi Deng, Fangfang Yang, Erfei Chen. Epigenetic Alteration in Colorectal Cancer: Potential Diagnostic and Prognostic Implications. International Journal of Molecular Sciences 2024; 25(6): 3358 doi: 10.3390/ijms25063358
|
| 17 |
Grzegorz Hibner, Małgorzata Kimsa-Furdzik, Tomasz Francuz. Relevance of MicroRNAs as Potential Diagnostic and Prognostic Markers in Colorectal Cancer. International Journal of Molecular Sciences 2018; 19(10): 2944 doi: 10.3390/ijms19102944
|
| 18 |
Li Chen, Man He, Meng Zhang, Qiang Sun, Sha Zeng, Hui Zhao, Han Yang, Maolun Liu, Shan Ren, Xianli Meng, Haibo Xu. The Role of non-coding RNAs in colorectal cancer, with a focus on its autophagy. Pharmacology & Therapeutics 2021; 226: 107868 doi: 10.1016/j.pharmthera.2021.107868
|
| 19 |
Ping Zhao, Yu-guang Ma, Yang Zhao, Di Liu, Zhi-jun Dai, Chang-you Yan, Hai-tao Guan. MicroRNA-552 deficiency mediates 5-fluorouracil resistance by targeting SMAD2 signaling in DNA-mismatch-repair-deficient colorectal cancer. Cancer Chemotherapy and Pharmacology 2019; 84(2): 427 doi: 10.1007/s00280-019-03866-7
|
| 20 |
Paul D. O'Dowd, Darragh F. Sutcliffe, Darren M. Griffith. Oxaliplatin and its derivatives – An overview. Coordination Chemistry Reviews 2023; 497: 215439 doi: 10.1016/j.ccr.2023.215439
|
| 21 |
Gerhard Jung, Eva Hernández-Illán, Leticia Moreira, Francesc Balaguer, Ajay Goel. Epigenetics of colorectal cancer: biomarker and therapeutic potential. Nature Reviews Gastroenterology & Hepatology 2020; 17(2): 111 doi: 10.1038/s41575-019-0230-y
|
| 22 |
Xiaoqun Lv, Guoxiong Xu. Regulatory role of the transforming growth factor-β signaling pathway in the drug resistance of gastrointestinal cancers. World Journal of Gastrointestinal Oncology 2021; 13(11): 1648-1667 doi: 10.4251/wjgo.v13.i11.1648
|
| 23 |
Mehrdad Hashemi, Nastaran Esbati, Mohsen Rashidi, Sadaf Gholami, Rasoul Raesi, Seyed Shahabadin Bidoki, Mohammad Ali Sheikh Beig Goharrizi, Yasamin Sadat Mousavi Motlagh, Ramin Khorrami, Alireza Tavakolpournegari, Noushin Nabavi, Rongjun Zou, Leila Mohammadnahal, Maliheh Entezari, Afshin Taheriazam, Kiavash Hushmandi. Biological landscape and nanostructural view in development and reversal of oxaliplatin resistance in colorectal cancer. Translational Oncology 2024; 40: 101846 doi: 10.1016/j.tranon.2023.101846
|
| 24 |
Yun Zhang, Hongmei Tang, Xiefang Yuan, Qin Ran, Xiaoyun Wang, Qi Song, Lei Zhang, Yuhuan Qiu, Xing Wang. TGF-β3 Promotes MUC5AC Hyper-Expression by Modulating Autophagy Pathway in Airway Epithelium. EBioMedicine 2018; 33: 242 doi: 10.1016/j.ebiom.2018.06.032
|
| 25 |
Atena Soleimani, Mehran Pashirzad, Amir Avan, Gordon A. Ferns, Majid Khazaei, Seyed Mahdi Hassanian. Role of the transforming growth factor‐β signaling pathway in the pathogenesis of colorectal cancer. Journal of Cellular Biochemistry 2019; 120(6): 8899 doi: 10.1002/jcb.28331
|
| 26 |
Reyhaneh Moradi Marjaneh, Majid Khazaei, Gordon A. Ferns, Amir Avan, Seyed Hamid Aghaee‐Bakhtiari. MicroRNAs as potential therapeutic targets to predict responses to oxaliplatin in colorectal cancer: From basic evidence to therapeutic implication. IUBMB Life 2019; 71(10): 1428 doi: 10.1002/iub.2108
|
| 27 |
Qinglian He, Ziqi Li, Jinbao Yin, Yuling Li, Yuting Yin, Xue Lei, Wei Zhu. Prognostic Significance of Autophagy-Relevant Gene Markers in Colorectal Cancer. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.566539
|
| 28 |
Chunhong Qu, Weifeng Dong, Shuli Yang. Polysaccharides Extracted from Angelica sinensis (Oliv.) Diels Relieve the Malignant Characteristics of Glioma Cells through Regulating the MiR-373-3p-Mediated TGF-β/Smad4 Signaling Pathway. Evidence-Based Complementary and Alternative Medicine 2022; 2022: 1 doi: 10.1155/2022/7469774
|
| 29 |
Kenneth KW To, Christy WS Tong, Mingxia Wu, William CS Cho. MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside. World Journal of Gastroenterology 2018; 24(27): 2949-2973 doi: 10.3748/wjg.v24.i27.2949
|
| 30 |
Teng Lv, Kejuan Song, Lili Zhang, Weihua Li, Yulong Chen, Yuchao Diao, Qin Yao, Peishu Liu. miRNA-34a decreases ovarian cancer cell proliferation and chemoresistance by targeting HDAC1. Biochemistry and Cell Biology 2018; 96(5): 663 doi: 10.1139/bcb-2018-0031
|
| 31 |
George Yiadom Osei, Joseph Adu-Amankwaah, Selina Koomson, Solomon Beletaa, Muhammad Khairi Ahmad, Emmanuel Akomanin Asiamah, Cecilia Smith-Togobo, Siti Razila Abdul Razak. Revolutionizing colorectal cancer treatment: unleashing the potential of miRNAs in targeting cancer stem cells. Future Oncology 2023; doi: 10.2217/fon-2023-0426
|
| 32 |
Lili Duan, Wanli Yang, Weibo Feng, Lu Cao, Xiaoqian Wang, Liaoran Niu, Yiding Li, Wei Zhou, Yujie Zhang, Jinqiang Liu, Hongwei Zhang, Qingchuan Zhao, Liu Hong, Daiming Fan. Molecular mechanisms and clinical implications of miRNAs in drug resistance of colorectal cancer. Therapeutic Advances in Medical Oncology 2020; 12: 175883592094734 doi: 10.1177/1758835920947342
|
| 33 |
Ammad Farooqi, Sobia Tabassum, Aamir Ahmad. MicroRNA-34a: A Versatile Regulator of Myriads of Targets in Different Cancers. International Journal of Molecular Sciences 2017; 18(10): 2089 doi: 10.3390/ijms18102089
|
| 34 |
Li Zhang, Hao Niu, Jie Ma, Bao-Ying Yuan, Yu-Han Chen, Yuan Zhuang, Gen-Wen Chen, Zhao-Chong Zeng, Zuo-Lin Xiang. The molecular mechanism of LncRNA34a-mediated regulation of bone metastasis in hepatocellular carcinoma. Molecular Cancer 2019; 18(1) doi: 10.1186/s12943-019-1044-9
|
| 35 |
Joseph Landry, Kathryn Shows, Akash Jagdeesh, Aashka Shah, Mihir Pokhriyal, Vasily Yakovlev. . The Enzymes 2023; 53: 113 doi: 10.1016/bs.enz.2023.07.007
|
| 36 |
Chixiong Huang, Senlin Huang, Hairui Li, Xinzhong Li, Bing Li, Lintao Zhong, Junfeng Wang, Meishen Zou, Xiang He, Hao Zheng, Xiaoyun Si, Wangjun Liao, Yulin Liao, Li Yang, Jianping Bin. The effects of ultrasound exposure on P-glycoprotein-mediated multidrug resistance in vitro and in vivo. Journal of Experimental & Clinical Cancer Research 2018; 37(1) doi: 10.1186/s13046-018-0900-6
|
| 37 |
Qiong Duan, Bin-Hui Chen, Yi Lin. Down-regulation of ClC-3 enhances chemosensitivity of colorectal cancer cells to oxaliplatin by inhibiting autophagy. World Chinese Journal of Digestology 2020; 28(24): 1235 doi: 10.11569/wcjd.v28.i24.1235
|
| 38 |
I-Ping Yang, Zhi-Feng Miao, Ching-Wen Huang, Hsiang-Lin Tsai, Yung-Sung Yeh, Wei-Chih Su, Tsung-Kun Chang, Se-fen Chang, Jaw-Yuan Wang. High blood sugar levels but not diabetes mellitus significantly enhance oxaliplatin chemoresistance in patients with stage III colorectal cancer receiving adjuvant FOLFOX6 chemotherapy. Therapeutic Advances in Medical Oncology 2019; 11: 175883591986696 doi: 10.1177/1758835919866964
|
| 39 |
Eunsun Jung, Jinhyeon Choi, Jang-Seong Kim, Tae-Su Han. MicroRNA-Based Therapeutics for Drug-Resistant Colorectal Cancer. Pharmaceuticals 2021; 14(2): 136 doi: 10.3390/ph14020136
|
| 40 |
Bashdar Mahmud Hussen, Sara Tharwat Abdullah, Snur Rasool Abdullah, Yousif Mohammed Younis, Hazha Jamal Hidayat, Mohammed Fatih Rasul, Sayran Mohamadtahr. Exosomal non-coding RNAs: Blueprint in colorectal cancer metastasis and therapeutic targets. Non-coding RNA Research 2023; 8(4): 615 doi: 10.1016/j.ncrna.2023.09.001
|
| 41 |
Tanu Sharma, James A. Radosevich, Chandi C. Mandal. Dual Role of microRNAs in Autophagy of Colorectal Cancer. Endocrine, Metabolic & Immune Disorders - Drug Targets 2021; 21(1): 56 doi: 10.2174/1871530320666200519075908
|
| 42 |
Changling Tu, Yufeng Wang, Xianshuo Cheng, Ying Zhu, Wenli Yuan, Jian Dong. The Combination Therapy of Fluorouracil and Oxaliplatin Suppress the Progression of Colon Cancer Through miR-183-5p/SOCS3 Axis and Downregulating PD-L1. Cancer Management and Research 2021; : 1999 doi: 10.2147/CMAR.S281925
|
| 43 |
Mutolib Olabayo Olatubosun, Murtala Bello Abubakar, Gaber El‐Saber Batiha, Ibrahim Malami, Kasimu Ghandi Ibrahim, Bilyaminu Abubakar, Muhammad Bashir Bello, Athanasios Alexiou, Mustapha Umar Imam. LncRNA SNHG15: A potential therapeutic target in the treatment of colorectal cancer. Chemical Biology & Drug Design 2023; 101(5): 1138 doi: 10.1111/cbdd.14036
|
| 44 |
Zheng-Dong Luo, Yi-Feng Wang, Yu-Xiao Zhao, Long-Chen Yu, Tian Li, Ying-Jing Fan, Shun-Jie Zeng, Yan-Li Zhang, Yi Zhang, Xin Zhang. Emerging roles of non-coding RNAs in colorectal cancer oxaliplatin resistance and liquid biopsy potential. World Journal of Gastroenterology 2023; 29(1): 1-18 doi: 10.3748/wjg.v29.i1.1
|
| 45 |
Lei Ding, Zhenwei Lan, Xianhui Xiong, Hongshun Ao, Yingting Feng, Huan Gu, Min Yu, Qinghua Cui. The Dual Role of MicroRNAs in Colorectal Cancer Progression. International Journal of Molecular Sciences 2018; 19(9): 2791 doi: 10.3390/ijms19092791
|
| 46 |
Xiao Juan Tang, Wei Wang, Swei Sunny Hann. Interactions among lncRNAs, miRNAs and mRNA in colorectal cancer. Biochimie 2019; 163: 58 doi: 10.1016/j.biochi.2019.05.010
|
| 47 |
Najah Albadari, Yang Xie, Wei Li. Deciphering treatment resistance in metastatic colorectal cancer: roles of drug transports, EGFR mutations, and HGF/c-MET signaling. Frontiers in Pharmacology 2024; 14 doi: 10.3389/fphar.2023.1340401
|
| 48 |
Zhi-Hua Li, Xueling Weng, Qiu-Yun Xiong, Jian-Hong Tu, An Xiao, Wei Qiu, Yu Gong, Er-Wei Hu, Songyin Huang, Ya-Li Cao. miR-34a expression in human breast cancer is associated with drug resistance. Oncotarget 2017; 8(63): 106270 doi: 10.18632/oncotarget.22286
|
| 49 |
Fatemeh Dashti, Seyed Mohammad Ali Mirazimi, Nikta Rabiei, Reza Fathazam, Negin Rabiei, Haleh Piroozmand, Massoud Vosough, Neda Rahimian, Michael R. Hamblin, Hamed Mirzaei. The role of non-coding RNAs in chemotherapy for gastrointestinal cancers. Molecular Therapy - Nucleic Acids 2021; 26: 892 doi: 10.1016/j.omtn.2021.10.004
|
| 50 |
Andrea Angius, Antonio Mario Scanu, Caterina Arru, Maria Rosaria Muroni, Vincenzo Rallo, Giulia Deiana, Maria Chiara Ninniri, Ciriaco Carru, Alberto Porcu, Giovanna Pira, Paolo Uva, Paolo Cossu-Rocca, Maria Rosaria De Miglio. Portrait of Cancer Stem Cells on Colorectal Cancer: Molecular Biomarkers, Signaling Pathways and miRNAome. International Journal of Molecular Sciences 2021; 22(4): 1603 doi: 10.3390/ijms22041603
|
| 51 |
Alexandra Gherman, Loredana Balacescu, Sinziana Gheorghe-Cetean, Catalin Vlad, Ovidiu Balacescu, Alexandru Irimie, Cosmin Lisencu. Current and New Predictors for Treatment Response in Metastatic Colorectal Cancer. The Role of Circulating miRNAs as Biomarkers. International Journal of Molecular Sciences 2020; 21(6): 2089 doi: 10.3390/ijms21062089
|
| 52 |
Shaista Manzoor, Jibran Sualeh Muhammad, Azzam A. Maghazachi, Qutayba Hamid. Autophagy: A Versatile Player in the Progression of Colorectal Cancer and Drug Resistance. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.924290
|
| 53 |
Wu Wei, Yang Xi, Xu Jiamin, Zhuang Jing, Han Shuwen. Screening of molecular targets and construction of a ceRNA network for oxaliplatin resistance in colorectal cancer. RSC Advances 2019; 9(54): 31413 doi: 10.1039/C9RA06146K
|
| 54 |
Saeid Ghavami, Mozhdeh Zamani, Mazaher Ahmadi, Mehran Erfani, Sanaz Dastghaib, Mahsa Darbandi, Sara Darbandi, Omid Vakili, Morvarid Siri, Beniamin Oskar Grabarek, Dariusz Boroń, Maryam Zarghooni, Emilia Wiechec, Pooneh Mokarram. Epigenetic regulation of autophagy in gastrointestinal cancers. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2022; 1868(11): 166512 doi: 10.1016/j.bbadis.2022.166512
|
| 55 |
Jiayu Zhang, Chenguang Li, Luanbiao Sun, Denghua Sun, Tiancheng Zhao. P53‑microRNA interactions regulate the response of colorectal tumor cells to oxaliplatin under normoxic and hypoxic conditions. Oncology Reports 2023; 50(6) doi: 10.3892/or.2023.8656
|
| 56 |
Madhav Madurantakam Royam, Chellan Kumarasamy, Siddhartha Baxi, Ajay Gupta, Nachimuthu Ramesh, Gothandam Kodiveri Muthukaliannan, Rama Jayaraj. Current Evidence on miRNAs as Potential Theranostic Markers for Detecting Chemoresistance in Colorectal Cancer: A Systematic Review and Meta-Analysis of Preclinical and Clinical Studies. Molecular Diagnosis & Therapy 2019; 23(1): 65 doi: 10.1007/s40291-019-00381-6
|
| 57 |
Fei Li, Xinji Li, Li Qiao, Wen Liu, Chengshan Xu, Xiaogang Wang. MALAT1 regulates miR-34a expression in melanoma cells. Cell Death & Disease 2019; 10(6) doi: 10.1038/s41419-019-1620-3
|
| 58 |
Zhenlv Lin, Lin Zhang, Junfeng Zhou, Jiantao Zheng. Silencing Smad4 attenuates sensitivity of colorectal cancer cells to cetuximab by promoting epithelial‑mesenchymal transition. Molecular Medicine Reports 2019; doi: 10.3892/mmr.2019.10597
|
| 59 |
Helon Guimarães Cordeiro, Alessandra Valéria de Sousa Faria, Carmen Veríssima Ferreira-Halder. Vemurafenib downmodulates aggressiveness mediators of colorectal cancer (CRC): Low Molecular Weight Protein Tyrosine Phosphatase (LMWPTP), Protein Tyrosine Phosphatase 1B (PTP1B) and Transforming Growth Factor β (TGFβ). Biological Chemistry 2020; 401(9): 1063 doi: 10.1515/hsz-2020-0124
|
| 60 |
Milad Ashrafizadeh, Ali Zarrabi, Kiavash Hushmandi, Farid Hashemi, Fardin Hashemi, Saeed Samarghandian, Masoud Najafi. MicroRNAs in cancer therapy: Their involvement in oxaliplatin sensitivity/resistance of cancer cells with a focus on colorectal cancer. Life Sciences 2020; 256: 117973 doi: 10.1016/j.lfs.2020.117973
|
| 61 |
Jiabei Zhou, Yu Kang, Lu Chen, Hua Wang, Junqing Liu, Su Zeng, Lushan Yu. The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor Agents. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.00343
|
| 62 |
Elham Fakhr, Fatemeh Zare, Kayhan Azadmanesh, Ladan Teimoori-Toolabi. LEF1 silencing sensitizes colorectal cancer cells to oxaliplatin, 5-FU, and irinotecan. Biomedicine & Pharmacotherapy 2021; 143: 112091 doi: 10.1016/j.biopha.2021.112091
|
| 63 |
Sanaz Naghizadeh, Ali Mohammadi, Pascal H. G. Duijf, Behzad Baradaran, Elham Safarzadeh, William Chi‐Shing Cho, Behzad Mansoori. The role of miR‐34 in cancer drug resistance. Journal of Cellular Physiology 2020; 235(10): 6424 doi: 10.1002/jcp.29640
|
| 64 |
Andrew J. Pellatt, Lila E. Mullany, Jennifer S. Herrick, Lori C. Sakoda, Roger K. Wolff, Wade S. Samowitz, Martha L. Slattery. The TGFβ-signaling pathway and colorectal cancer: associations between dysregulated genes and miRNAs. Journal of Translational Medicine 2018; 16(1) doi: 10.1186/s12967-018-1566-8
|
| 65 |
Yanqiu Wang, Jun Xiang, Jianjun Wang, Yazhong Ji. Downregulation of TGF-β1 suppressed proliferation and increased chemosensitivity of ovarian cancer cells by promoting BRCA1/Smad3 signaling. Biological Research 2018; 51(1) doi: 10.1186/s40659-018-0205-4
|
| 66 |
Reyhaneh Moradi-Marjaneh, Majid Khazaei, Gordon A. Ferns, Seyed H. Aghaee-Bakhtiari. The Role of TGF-β Signaling Regulatory MicroRNAs in the Pathogenesis of Colorectal Cancer. Current Pharmaceutical Design 2019; 24(39): 4611 doi: 10.2174/1381612825666190110150705
|
| 67 |
Hanla A. Park, Petra Seibold, Dominic Edelmann, Axel Benner, Federico Canzian, Elizabeth Alwers, Lina Jansen, Martin Schneider, Michael Hoffmeister, Hermann Brenner, Jenny Chang-Claude. Validation of Genetic Markers Associated with Survival in Colorectal Cancer Patients Treated with Oxaliplatin-Based Chemotherapy. Cancer Epidemiology, Biomarkers & Prevention 2022; 31(2): 352 doi: 10.1158/1055-9965.EPI-21-0814
|
| 68 |
Priyanka Sharma, Ilaria Dando, Raffaele Strippoli, Suresh Kumar, Alvaro Somoza, Marco Cordani, Marco Tafani. Nanomaterials for Autophagy-Related miRNA-34a Delivery in Cancer Treatment. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.01141
|
| 69 |
Yuhe Lei, Lei Chen, Junshan Liu, Yinqin Zhong, Lijuan Deng. The MicroRNA-Based Strategies to Combat Cancer Chemoresistance via Regulating Autophagy. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.841625
|
| 70 |
Xin Tian, Guangwei Zhang, Hui Zhao, Yang Li, Chaoyang Zhu. Long non-coding RNA NEAT1 contributes to docetaxel resistance of prostate cancer through inducing RET expression by sponging miR-34a. RSC Advances 2017; 7(68): 42986 doi: 10.1039/C7RA06107B
|
| 71 |
Qun Li, Wei Song, Jianmin Wang. TUG1 confers Adriamycin resistance in acute myeloid leukemia by epigenetically suppressing miR-34a expression via EZH2. Biomedicine & Pharmacotherapy 2019; 109: 1793 doi: 10.1016/j.biopha.2018.11.003
|
| 72 |
Sijing Li, Xiaohui Wei, Jinyong He, Quanquan Cao, Danyu Du, Xiaoman Zhan, Yuqi Zeng, Shengtao Yuan, Li Sun. The comprehensive landscape of miR-34a in cancer research. Cancer and Metastasis Reviews 2021; 40(3): 925 doi: 10.1007/s10555-021-09973-3
|
| 73 |
Stergios Boussios, Mehmet Ozturk, Michele Moschetta, Afroditi Karathanasi, Nikolaos Zakynthinakis-Kyriakou, Konstantinos Katsanos, Dimitrios Christodoulou, Nicholas Pavlidis. The Developing Story of Predictive Biomarkers in Colorectal Cancer. Journal of Personalized Medicine 2019; 9(1): 12 doi: 10.3390/jpm9010012
|
| 74 |
Bin Xiong, Qiaoyi Huang, Huida Zheng, Shu Lin, Jianhua Xu. Recent advances microRNAs and metabolic reprogramming in colorectal cancer research. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1165862
|
| 75 |
Zhen-Hua Yang, Yan-Qi Dang, Guang Ji. Role of epigenetics in transformation of inflammation into colorectal cancer. World Journal of Gastroenterology 2019; 25(23): 2863-2877 doi: 10.3748/wjg.v25.i23.2863
|
| 76 |
Xijuan Chen, Junqi Liu, Qinglan Zhang, Baoxing Liu, Yan Cheng, Yonglei Zhang, Yanan Sun, Hong Ge, Yingqiang Liu. Exosome-mediated transfer of miR-93-5p from cancer-associated fibroblasts confer radioresistance in colorectal cancer cells by downregulating FOXA1 and upregulating TGFB3. Journal of Experimental & Clinical Cancer Research 2020; 39(1) doi: 10.1186/s13046-019-1507-2
|
| 77 |
Mohamed J. Saadh, Omer Qutaiba B. Allela, Zahraa Jasim Sattay, Rafil Adnan Hussein Al Zuhairi, Hijaz Ahmad, Gaber E. Eldesoky, Mohaned Adil, Mohammed Shnain Ali. Deciphering the functional landscape and therapeutic implications of noncoding RNAs in the TGF-β signaling pathway in colorectal cancer: A comprehensive review. Pathology - Research and Practice 2024; 255: 155158 doi: 10.1016/j.prp.2024.155158
|
| 78 |
Yu‐Zhu Wu, Hong‐Yue Lin, Yin Zhang, Wen‐Fa Chen. miR‐200b‐3p mitigates oxaliplatin resistance via targeting TUBB3 in colorectal cancer. The Journal of Gene Medicine 2020; 22(7) doi: 10.1002/jgm.3178
|